Work

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Year: 2020

Type: article

Study design: Clinical Trial

Source: Nature Medicine

DOI: 10.1038/s41591-020-1074-2

Authors: Andras Heczey, Amy N. Courtney, Antonino Montalbano, Simon Robinson, Ka Liu, Mingmei Li, Nisha Ghatwai, Olga Dakhova, Bin Liu, Tali Raveh-Sadka, Cynthia N. Chauvin-Fleurence, Xin Xu, Ho Ngai, Erica J. Di Pierro, Barbara Savoldo, Gianpietro Dotti, Leonid S. Metelitsa

Institutions: Baylor College of Medicine, Immunai (United States), University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, Alex's Lemonade Stand Foundation for Childhood Cancer, Cancer Prevention and Research Institute of Texas, National Cancer Institute

Awards: Cellular Immunotherapy of Ovarian Cancer, Baylor College of Medicine Comprehensive Cancer Training Program

OpenAlex ID: W3092444112

FWCI: 12.59

Cites: 34

Cited by: 286

Related to: 10